tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Coya Therapeutics reports Q2 EPS (36c), consensus (43c)
PremiumThe FlyCoya Therapeutics reports Q2 EPS (36c), consensus (43c)
18d ago
Is COYA a Buy, Before Earnings?
Premium
Pre-Earnings
Is COYA a Buy, Before Earnings?
21d ago
Coya Therapeutics publishes new research study on progression of Parkinson’s
Premium
The Fly
Coya Therapeutics publishes new research study on progression of Parkinson’s
1M ago
Coya Therapeutics: Strengthened Patent Estate and Upcoming Catalysts Support Buy Rating
PremiumRatingsCoya Therapeutics: Strengthened Patent Estate and Upcoming Catalysts Support Buy Rating
3M ago
Coya Therapeutics initiated with a Buy at Lucid Capital
Premium
The Fly
Coya Therapeutics initiated with a Buy at Lucid Capital
3M ago
Coya Therapeutics announces issuance of new U.S. patent for IL-2
Premium
The Fly
Coya Therapeutics announces issuance of new U.S. patent for IL-2
3M ago
Promising Outlook for Coya Therapeutics: Buy Rating Justified by Innovative Treatments and Pipeline Potential
PremiumRatingsPromising Outlook for Coya Therapeutics: Buy Rating Justified by Innovative Treatments and Pipeline Potential
4M ago
Coya Therapeutics reports interim results from IL-2, CTLA4-Ig combination study
Premium
The Fly
Coya Therapeutics reports interim results from IL-2, CTLA4-Ig combination study
4M ago
Coya Therapeutics announces publication of study results on COYA 303
Premium
The Fly
Coya Therapeutics announces publication of study results on COYA 303
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100